Cargando…

Regadenoson cardiovascular magnetic resonance myocardial perfusion imaging predicts need for future revascularization

Detalles Bibliográficos
Autores principales:	Freed, Benjamin H, Turner, Kristen M, Yodwut, Chattanong, Tarroni, Giacomo, Estep, Emily, Bhave, Nicole M, Narang, Akhil, Tanaka, Sara, Corsi, Cristiana, Gayat, Etienne, Czobor, Peter, Cavanaugh, Kevin, Lang, Roberto, Mor-Avi, Victor, Patel, Amit R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305691/ http://dx.doi.org/10.1186/1532-429X-14-S1-P7

Ejemplares similares

Lipid sub-fractionation predicts worsening myocardial perfusion reserve in patients with low-density lipoprotein less than 100mg/dL: a regadenoson dardiac magnetic resonance study
por: Narang, Akhil, et al.
Publicado: (2012)

A vasodilator stress MRI perfusion study: large HDL particle number is independently associated with microvascular function in patients with LDL-C <100mg/dL
por: Narang, Akhil, et al.
Publicado: (2013)

Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson
por: Bhave, Nicole M, et al.
Publicado: (2012)

Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance
por: Freed, Benjamin H, et al.
Publicado: (2013)

Automated quantification of myocardial perfusion based on segmentation and non-rigid registration of contrast-enhanced cardiac magnetic resonance images
por: Tarroni, Giacomo, et al.
Publicado: (2011)

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015)

Mechanistic insights and characterization of cardiomyopathy due to Sickle Cell Disease
por: Patel, Amit R, et al.
Publicado: (2012)

Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019)

Diagnostic performance of regadenoson stress CMR for detection of coronary artery disease
por: Patel, Mita, et al.
Publicado: (2015)

Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013)

Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014)

Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging
por: Ahmad, Tanjeev, et al.
Publicado: (2021)

Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR
por: Muñiz-Sáenz-Diez, Javier, et al.
Publicado: (2023)

Regadenoson in Myocardial Perfusion Study - First Institutional Experiences in Bosnia and Herzegovina
por: Beslic, Nermina, et al.
Publicado: (2016)

Comparison of Regadenoson and Dipyridamole Safety Profiles During Stress Myocardial Perfusion Imaging
por: Roczniak, Jan, et al.
Publicado: (2023)

Optimal timing of rest perfusion with regadenoson stress testing - normal volunteer study of quantitative MRI perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Cardiovascular effects and tolerance of adenosine versus regadenoson during cardiac MRI perfusion testing
por: Minor, Matthew, et al.
Publicado: (2015)

Regadenoson administration and QT interval prolongation during pharmacological radionuclide myocardial perfusion imaging
por: Rafiq, Arsalan, et al.
Publicado: (2020)

Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
por: Kero, Tanja, et al.
Publicado: (2021)

Vasodilator stress cardiovascular magnetic resonance imaging in post-orthotopic heart transplant recipients: evaluation of safety, hemodynamics, and myocardial perfusion
por: Narang, Akhil, et al.
Publicado: (2016)

Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Editorial: Regadenoson: An adenosine A(2A) receptor agonist for pharmacological myocardial perfusion imaging
por: Matsuo, Shinro
Publicado: (2014)

Safety and Efficacy of Regadenoson for Pediatric Stress Perfusion Cardiac MRI with Quantification of Myocardial Blood Flow
por: Patel, Shivani G., et al.
Publicado: (2022)

Regadenoson in the detection of coronary artery disease
por: Buhr, Christiane, et al.
Publicado: (2008)

The EXERRT trial: “EXErcise to Regadenoson in Recovery Trial”: A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol
por: Thomas, Gregory S., et al.
Publicado: (2017)

Determinants of myocardial perfusion reserve measured from coronary sinus phase-contrast imaging during regadenoson stress CMR
por: Bauml, Michael A, et al.
Publicado: (2014)

Feasibility and preliminary diagnostic results of pixel-wise quantification of regadenoson first pass cardiac magnetic resonance perfusion imaging
por: Ta, Allison D, et al.
Publicado: (2014)

Initial results of a new very rapid rest/regadenoson stress myocardial perfusion protocol in patients with atrial fibrillation
por: Chang, Lowell, et al.
Publicado: (2014)

Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study
por: Tejani, Furqan H., et al.
Publicado: (2014)

Regadenoson myocardial perfusion scintigraphy for the evaluation of coronary artery disease in patients with lung disease: A series of five cases
por: Reyes, Eliana, et al.
Publicado: (2019)

Adenosine vs. regadenoson for stress induction in dynamic CT perfusion scan of the myocardium: A single‑center retrospective comparison
por: Gibarti, Claudia, et al.
Publicado: (2023)

Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Transient Ischemic Dilation Ratio in Regadenoson, Single Isotope Gated Single-photon Emission Computed Tomography Myocardial Perfusion Imaging
por: Rubio, Manolo, et al.
Publicado: (2017)

Impaired coronary vasodilation with Regadenoson in patients with angiographically normal coronaries when compared to normal volunteers - Insights from Quantitative MRI Perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Regadenoson-Stress Dynamic Myocardial Perfusion Improves Diagnostic Performance of CT Angiography in Assessment of Intermediate Coronary Artery Stenosis in Asymptomatic Patients
por: Baxa, Jan, et al.
Publicado: (2015)

Caffeine Consumption and Heart Rate and Blood Pressure Response to Regadenoson
por: Bitar, Abbas, et al.
Publicado: (2015)

Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping
por: van Dijk, R., et al.
Publicado: (2017)

Objective selection of short-axis slices for automated quantification of left ventricular size and function by cardiovascular magnetic resonance
por: Marino, Marco, et al.
Publicado: (2015)

Time resolved measure of coronary sinus flow following regadenoson administration
por: Booker, O Julian, et al.
Publicado: (2011)

Regadenoson stress induced wall motion abnormalities during cardiac MRI
por: Parikh, Kalindi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2p3dq9bko9ic48ie92gscclv5c